-
Discover SeqOne GenomeAlert! A variant reevaluation automation agent to improve patient care.
See demo -
Oxford Nanopore Technologies and SeqOne partner to support interpretation of nanopore sequencing in clinical use.
Learn more -
We are pleased to announce the appointment of Martin Dubuc as new Chief Executive Officer of SeqOne Genomics.
Click here to learn more >
Introducing the most advanced platform for clinical genomic analysis…
Don’t miss
a mutation
State-of-the-art bioinformatics tools that identify complex genomic events overlooked by standard bioinformatic pipelines
Increase your team’s productivity
End-to-end germline and somatic analysis solution that manages the entire process from raw data to the clinical report
Meet quality and compliance goals
Tools to help you meet your quality control and regulatory compliance goals with support for your team in their efforts
Keep your data safe and accessible
Scalable and secure architecture that simplifies data management and meets your security and confidentiality requirements
Using data and machine learning to build a
more accurate picture of each patient
We are passionate about creating bioinformatic solutions that target hard-to-detect variants such as MNVs, Alu elements and mid-sized deletions. These challenging variants are important because research continues to discover ways in which they impact patient health. Our custom bioinformatic modules complement the industry-standard bioinformatic tools, making it possible to detect important variants that would otherwise be undetected.
SeqOne regularly publishes and shares many of its research results via the open source community.
Satisfied customers
About SeqOne
The vision uniting the SeqOne team is a desire to improve patient outcomes with improved genomic analysis. We use significant resources on research and development to ensure that our platform offers the most effective, easy-to-use solution.
This ambitious program is driven by a team of experts covering all aspects of medical genomics; from clinicians, bioinformaticians, biologists and information technology specialists to experts in algorithmics, artificial intelligence, security and big data.
SeqOne News
-
Platform features19 April 2024
SeqOne GenomeAlert! A variant reevaluation automation agent to improve patient care.
Transforming Patient Care through Advanced Variant Reevaluation In clinical genetics, the accurate classification of genetic variants as benign, variants of uncertain significance (VUS), or pathogenic [...]
-
News10 March 2024
Oxford Nanopore Technologies and SeqOne partner to support interpretation of nanopore sequencing in clinical use
A new partnership will provide end-to-end solutions from sample to report for whole genome nanopore sequencing reads at scale in future clinical applications, including rare [...]
-
Events14 February 2024
Genomic data interpretation workshop & lunch seminar in Heidelberg
We will be hosting a workshop & lunch seminar about genomic data interpretation. DATE: April 30th 2024, starting at 10:00, with lunch at 12:00 LOCATION: [...]
-
Blog Science2 February 2024
Evaluating Pathogenicity Scoring system for Missense Variants on real-world data: A comparison between AlphaMissense and SeqOne DiagAI pathogenicity score
Context Predicting the impact of missense mutations remains a significant and complex challenge in human genetics. Approximately 98% of these amino acid substitutions are classified [...]